Prognose des Bioprozessmarkts im asiatisch-pazifischen Raum bis 2031 – Regionale Analyse – nach Produkt (Instrumente, Verbrauchsmaterialien und Zubehör), Betriebsgröße (kommerzieller Betrieb und klinischer Betrieb), Prozess (Downstream-Bioprozess und Upstream-Bioprozess), Anwendung (monoklonale Antikörper, Impfstoffe, rekombinante Proteine, Zell- und Gentherapie und andere) und Endbenutzer (biopharmazeutische Unternehmen, Auftragsfertigungsorganisationen und andere)
Steigende Nachfrage nach personalisierter Medizin beflügelt den Markt für Bioverarbeitung im asiatisch-pazifischen Raum
Die Transformation der Gesundheitsbranche von einer Einheitslösung zu einem zielgerichteten Ansatz erhöht die Nachfrage nach personalisierter Medizin. Präzisionsmedizin gilt als einer der vielversprechendsten Ansätze zur Bekämpfung von Gesundheitsproblemen wie Krebs, neurodegenerativen Erkrankungen und seltenen genetischen Erkrankungen. Innovationen bei der Herstellung personalisierter Medikamente werden wahrscheinlich den gesamten Sektor beeinflussen, und Einwegtechnologien, die auf die Produktion kleinerer Mengen abzielen, haben potenzielle Anwendungen in der Proteinbioproduktion, insbesondere in nachgelagerten Prozessen. Personalisierte und differenzierte Ansätze in der Medizin führen zu einem Bedarf an einer breiteren Produktpalette – viele davon für eine relativ kleine Gruppe von Patienten. Daher kann ein grundlegend anderer Ansatz für die Herstellung und Bereitstellung biologischer Produkte erforderlich sein. Die Präzisionsmedizin nutzt die genomischen Informationen eines Individuums, um eine gezielte Behandlung für eine bestimmte Indikation anzubieten. Die wachsende Zahl seltener Krankheiten hat die Nachfrage nach Biologika und Arzneimitteln erhöht, was wiederum das Wachstum personalisierter Medikamente gefördert hat. Im Jahr 2019 genehmigte die FDA etwa 12 personalisierte Medikamente zur Behandlung der Grundursachen von Krankheiten und zur weiteren Integration der Präzisionsmedizin in die klinische Versorgung. Auch zunehmende staatliche Bemühungen stärken die Forschungsaktivitäten im Bereich der personalisierten Medizin. So kündigte das National Human Genome Research Institute (NHGRI) im Februar 2020 die Einrichtung eines neuen Programms für Präzisionsmedizin und Genomik an. Dieses Programm konzentriert sich auf die Innovation von Genomik- und Informatik-Tools zur besseren Diagnose und Behandlung von Krankheiten. Personalisierte Medikamente nutzen Fortschritte in der Genetik und Bioinformatik, um bestimmte Patientengruppen anzusprechen und bisher nicht behandelbare Krankheiten zu behandeln. Die personalisierte Medizin verwendet Bioverarbeitungstechniken, um maßgeschneiderte Therapien zu entwickeln. Von der Isolierung spezifischer Zellen bis zur Entwicklung patientenspezifischer Behandlungen sind Bioverarbeitungsschritte für die Herstellung maßgeschneiderter Behandlungen für jeden Patienten von entscheidender Bedeutung. Daher wird prognostiziert, dass die steigende Nachfrage nach personalisierter Medizin den Akteuren auf dem Bioprozessmarkt im Prognosezeitraum erhebliche Wachstumschancen bieten wird.
Überblick über den Bioprozessmarkt im asiatisch-pazifischen Raum
Der Bioprozessmarkt im asiatisch-pazifischen Raum ist in China, Japan, Indien, Südkorea, Australien und den Rest des asiatisch-pazifischen Raums unterteilt. Das Marktwachstum in diesen Ländern wird auf die steigende Prävalenz chronischer Krankheiten und günstige Erstattungsrichtlinien zurückgeführt. Darüber hinaus wird erwartet, dass die von den Marktteilnehmern umgesetzten Expansions- und Produkteinführungsstrategien zum Wachstum des Marktes für Bioprozesstechnologie in der Region beitragen werden. China hatte im Jahr 2023 den größten Marktanteil, und Indien wird im Prognosezeitraum voraussichtlich eine signifikante CAGR auf dem Markt verzeichnen. Die biopharmazeutische Industrie in China erlebt einen enormen Wandel und entwickelt sich von einer auf Generika ausgerichteten Landschaft zu einem florierenden Innovationszentrum. Darüber hinaus tragen Fortschritte bei der Industrialisierung und der Anwendung neuartiger Medikamente, hochwertiger medizinischer Geräte und Techniken zum Wachstum des Bioprozessmarktes in China bei. So treiben eine zunehmende Zahl von Forschungszentren, steigende staatliche Finanzierung und ständige Initiativen der Marktteilnehmer zur geografischen Expansion das Wachstum des Bioverarbeitungsmarktes im asiatisch-pazifischen Raum voran.
Umsatz und Prognose des Bioverarbeitungsmarktes im asiatisch-pazifischen Raum bis 2031 (Mio. USD)
Segmentierung des Bioverarbeitungsmarktes im asiatisch-pazifischen Raum
Der Bioverarbeitungsmarkt im asiatisch-pazifischen Raum ist nach Produkt, Betriebsgröße, Prozess, Anwendung, Endbenutzer und Land kategorisiert.
Basierend auf dem Produkt ist der Bioverarbeitungsmarkt im asiatisch-pazifischen Raum in Instrumente und Verbrauchsmaterialien & Zubehör unterteilt. Das Instrumentensegment hielt 2023 einen größeren Marktanteil. Darüber hinaus ist das Instrumentensegment in Filtrationsgeräte, Bioreaktoren, Chromatographiesysteme, Zentrifugen, Trocknungsgeräte und andere unterteilt. Darüber hinaus ist das Untersegment Bioreaktoren in Pilotmaßstab, Vollmaßstab und Labormaßstab unterteilt. Darüber hinaus ist das Untersegment Chromatographiesysteme in Flüssigchromatographie, Gaschromatographie und andere unterteilt. Darüber hinaus ist das Segment Verbrauchsmaterialien und Zubehör in Reagenzien, Zellkulturmedien, Chromatographieharze und andere unterteilt.
In Bezug auf den Betriebsumfang ist der Bioverarbeitungsmarkt im asiatisch-pazifischen Raum in kommerzielle und klinische Operationen unterteilt. Das Segment der kommerziellen Operationen hatte 2023 einen größeren Marktanteil.
Nach Prozess ist der Bioverarbeitungsmarkt im asiatisch-pazifischen Raum in Downstream-Bioprozesse und Upstream-Bioprozesse unterteilt. Das Segment der Downstream-Bioprozesse hatte 2023 einen größeren Marktanteil.
Basierend auf der Anwendung ist der Bioverarbeitungsmarkt im asiatisch-pazifischen Raum in monoklonale Antikörper, Impfstoffe, rekombinante Proteine, Zell- und Gentherapie und andere unterteilt. Das Segment der monoklonalen Antikörper hatte 2023 den größten Marktanteil.
In Bezug auf den Endbenutzer ist der Bioverarbeitungsmarkt im asiatisch-pazifischen Raum in biopharmazeutische Unternehmen, Auftragsfertigungsorganisationen und andere unterteilt. Das Segment der biopharmazeutischen Unternehmen hatte 2023 den größten Marktanteil.
Nach Ländern ist der Bioverarbeitungsmarkt im asiatisch-pazifischen Raum in China, Indien, Japan, Südkorea, Australien und den Rest des asiatisch-pazifischen Raums unterteilt. China dominierte 2023 den Marktanteil der Bioverarbeitung im asiatisch-pazifischen Raum.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc und Cytiva US LLC. sind einige der führenden Unternehmen auf dem Bioverarbeitungsmarkt im asiatisch-pazifischen Raum.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. Asia Pacific Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - Asia Pacific Analysis
6.1 Asia Pacific Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. Asia Pacific Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Asia Pacific Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Asia Pacific Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Asia Pacific Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. Asia Pacific Bioprocessing Market - Country Analysis
12.1 Asia Pacific
12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product
12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process
12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application
12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User
12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product
12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process
12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application
12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User
12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product
12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process
12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application
12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User
12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Overview
12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product
12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process
12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application
12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User
12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.9.1 Overview
12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product
12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process
12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application
12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User
12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.11.1 Overview
12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Repligen Corp
- Entegris Inc
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.